Search research articles
Contact Us
Filters
Showing results (211-220 of 315) with videos related to
Page
of 32
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 18, 2005
Phase I pharmacokinetic and pharmacodynamic study of 17-allylamino, 17-demethoxygeldanamycin in patients with advanced malignancies
Udai Banerji, Anne O'Donnell, Michelle Scurr, et al.
Drug Discovery Today
|
December 8, 2009
Can molecular biomarker-based patient selection in Phase I trials accelerate anticancer drug development?
Craig P Carden, Debashis Sarker, Sophie Postel-Vinay, et al.
Bioorganic & Medicinal Chemistry
|
July 3, 2007
Synthesis and biological evaluation of sulfonylhydrazone-substituted imidazo[1,2-a]pyridines as novel PI3 kinase p110alpha inhibitors
Masahiko Hayakawa, Ken-Ichi Kawaguchi, Hiroyuki Kaizawa, et al.
Molecular Cancer Therapeutics
|
September 3, 2011
The aurora kinase inhibitor CCT137690 downregulates MYCN and sensitizes MYCN-amplified neuroblastoma in vivo
Amir Faisal, Lynsey Vaughan, Vassilios Bavetsias, et al.
Oncogene
|
February 26, 2020
Correction: Signalling involving MET and FAK supports cell division independent of the activity of the cell cycle-regulating CDK4/6 kinases
Chi Zhang, Simon R Stockwell, May Elbanna, et al.
Oncogene
|
July 13, 2019
Signalling involving MET and FAK supports cell division independent of the activity of the cell cycle-regulating CDK4/6 kinases
Chi Zhang, Simon R Stockwell, May Elbanna, et al.
Journal of Molecular Biology
|
February 6, 2007
A structural comparison of inhibitor binding to PKB, PKA and PKA-PKB chimera
Thomas G Davies, Marcel L Verdonk, Brent Graham, et al.
Plos One
|
July 14, 2017
In vitro nuclear magnetic resonance spectroscopy metabolic biomarkers for the combination of temozolomide with PI3K inhibition in paediatric glioblastoma cells
Nada M S Al-Saffar, Alice Agliano, Lynley V Marshall, et al.
Nature Communications
|
February 17, 2026
R-loop editing by DNA cytosine deaminase APOBEC3B modulates the activity of oestrogen receptor enhancers
Chi Zhang, Yu-Jing Lu, Bingjie Chen, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 17, 2006
4-Amino derivatives of the Hsp90 inhibitor CCT018159
Xavier Barril, Mandy C Beswick, Adam Collier, et al.
Page
of 32
Search research articles
Search
Showing results (211-220 of 315) with videos related to
Sort By:
Page
of 32
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 18, 2005
Phase I pharmacokinetic and pharmacodynamic study of 17-allylamino, 17-demethoxygeldanamycin in patients with advanced malignancies
Udai Banerji, Anne O'Donnell, Michelle Scurr, et al.
Drug Discovery Today
|
December 8, 2009
Can molecular biomarker-based patient selection in Phase I trials accelerate anticancer drug development?
Craig P Carden, Debashis Sarker, Sophie Postel-Vinay, et al.
Bioorganic & Medicinal Chemistry
|
July 3, 2007
Synthesis and biological evaluation of sulfonylhydrazone-substituted imidazo[1,2-a]pyridines as novel PI3 kinase p110alpha inhibitors
Masahiko Hayakawa, Ken-Ichi Kawaguchi, Hiroyuki Kaizawa, et al.
Molecular Cancer Therapeutics
|
September 3, 2011
The aurora kinase inhibitor CCT137690 downregulates MYCN and sensitizes MYCN-amplified neuroblastoma in vivo
Amir Faisal, Lynsey Vaughan, Vassilios Bavetsias, et al.
Oncogene
|
February 26, 2020
Correction: Signalling involving MET and FAK supports cell division independent of the activity of the cell cycle-regulating CDK4/6 kinases
Chi Zhang, Simon R Stockwell, May Elbanna, et al.
Oncogene
|
July 13, 2019
Signalling involving MET and FAK supports cell division independent of the activity of the cell cycle-regulating CDK4/6 kinases
Chi Zhang, Simon R Stockwell, May Elbanna, et al.
Journal of Molecular Biology
|
February 6, 2007
A structural comparison of inhibitor binding to PKB, PKA and PKA-PKB chimera
Thomas G Davies, Marcel L Verdonk, Brent Graham, et al.
Plos One
|
July 14, 2017
In vitro nuclear magnetic resonance spectroscopy metabolic biomarkers for the combination of temozolomide with PI3K inhibition in paediatric glioblastoma cells
Nada M S Al-Saffar, Alice Agliano, Lynley V Marshall, et al.
Nature Communications
|
February 17, 2026
R-loop editing by DNA cytosine deaminase APOBEC3B modulates the activity of oestrogen receptor enhancers
Chi Zhang, Yu-Jing Lu, Bingjie Chen, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 17, 2006
4-Amino derivatives of the Hsp90 inhibitor CCT018159
Xavier Barril, Mandy C Beswick, Adam Collier, et al.
Page
of 32